Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-014069
Filing Date
2014-09-10
Accepted
2014-09-10 19:09:27
Documents
2
Period of Report
2014-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2242
2 POWER OF ATTORNEY leepoa.txt EX-24..TXT 3382
  Complete submission text file 0001179110-14-014069.txt   6992
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
LEE JUNNING (Reporting) CIK: 0001596187 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36033 | Film No.: 141096768